Zobrazeno 1 - 10
of 87
pro vyhledávání: '"D. A. G. Galton"'
Autor:
D. A. G. Galton, S. D. Lawler
Publikováno v:
Acta Medica Scandinavica. 179:312-318
Autor:
F. Brito-Babapulle, D. A. G. Galton
Publikováno v:
European Journal of Haematology. 39:385-398
Publikováno v:
Scandinavian Journal of Haematology. 9:142-148
Polymorphonuclear neutrophils (PMN) lacking myeloperoxidase (MP) were found in 12 out of 28 (43 %) cases of acute myeloid leukaemia (AML) and in 2 out of 7 (28 %) cases of ‘blast-cell transformation’ of chronic granulocytic leukaemia. This abnorm
Autor:
D. A. G. Galton
Publikováno v:
Ciba Foundation Symposium-Chemistry and Biology of Purines
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a571971777d3fef680327c71140faefc
https://doi.org/10.1002/9780470719015.ch23
https://doi.org/10.1002/9780470719015.ch23
Autor:
D. A. G. Galton, Eve Wiltshaw
Publikováno v:
Ciba Foundation Symposium-Amino Acids and Peptides with Antimetabolic Activity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a8abf1dfbe51756bbd0200cc425c6026
https://doi.org/10.1002/9780470719114.ch8
https://doi.org/10.1002/9780470719114.ch8
Autor:
Harvey R. Gralnick, Daniel Catovsky, Marie-Thérèse Daniel, Cheryl L. Willman, John M. Bennett, D. A. G. Galton, Georges Flandrin
Publikováno v:
Leukemia. 14(7)
The FAB group has reviewed 32 cases of promyelocytic leukemia and variant forms. By utilizing published criteria the ability to make a correct diagnosis by morphology with molecular genetic confirmation and to eliminate cases that did not have the PM
Autor:
D. A. G. Galton
Publikováno v:
Leukemialymphoma. 7(5-6)
Chronic myeloid leukaemia (CML) is a generic term that include five apparently distinct entities. The best known form, the classical Ph-positive subtype, accounts for about 90% of all cases of CML. The morphology of its presentation blood film is hig
Publikováno v:
Myelodysplastic Syndromes ISBN: 9783540529668
Chronic myelomonocytic leukaemia (CMML) has attracted interest in two contexts in recent years. First, the FAB Cooperative Group [3] has classified it as a myelodysplastic syndrome (MDS) characterised by the presence in the peripheral blood of more t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cb7304e6e4e51f5eea02d4fd4960ebcb
https://doi.org/10.1007/978-3-642-75952-9_21
https://doi.org/10.1007/978-3-642-75952-9_21
Autor:
John M. Bennett, G. Flandrin, D. Catovsky, D. A. G. Galton, M. T. Daniel, H. R. Gralnick, C. Sultan
Publikováno v:
British journal of haematology. 78(3)
We describe a form of acute myeloid leukaemia (AML), designated AML-MO, with minimal myeloid differentiation, not included previously in the FAB classification. AML-MO cannot be diagnosed on morphological grounds alone as the blast cells are large an